Skip to content

Enhancing Dialysis Adequacy: Effects of Intradialytic Exercise

Intradialytic Exercise for Enhanced Dialysis Adequacy and Solute Removal in Chronic Kidney Disease Patients: A Randomised Controlled Trial.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01481688
Enrollment
14
Registered
2011-11-29
Start date
2011-11-30
Completion date
2012-01-31
Last updated
2011-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

Dialysis adequacy, Urea clearance, Phosphate clearance, Beta 2 microglobulin clearance, Intradialytic exercise, Haemodialysis patients

Brief summary

The purpose of this study is to investigate whether intradialytic exercise increases removal of waste products from blood, in comparison to the traditional prescription of increasing dialysis duration.

Detailed description

For patients with severe chronic kidney disease, regular dialysis to remove toxins and waste products from the blood is essential to maintain life. The adequacy of dialysis is quantified by the removal of these toxic solutes and is an important parameter in the assessment of the therapy. Previous efforts to enhance urea clearance have centered around factors such as increasing dialysis dose by increasing dialysis time or carrying out more frequent dialysis sessions. However this concept is confronted with the barriers of patient compliance and cost implications. Many patients are resilient to increasing their dialysis time, presenting a major challenge for enhancing the efficacy of dialysis therapy. Therefore, alternative methods of improving dialysis adequacy, with interventions aimed at enhancing solute clearance, are highly warranted. One such intervention could be exercising during haemodialysis (HD). 85% of the body is comprised of lean tissue, of which 73% is water. As many toxic solutes are water based, large amounts will be stored in the muscle. When sitting at rest during HD the blood flow to the muscles is four times less compared to the major organs. Additionally, the HD process causes blood vessels to constrict, further restricting blood flow to the muscle. Consequently there is insufficient blood flow to remove the toxins stored in the muscle. By exercising during dialysis, blood flow to the muscle is increased to sustain the demand for oxygen and energy, thereby allowing toxic solutes to be removed and cleared through the dialysis machine. Therefore the aim of this study is to implement an efficient exercise intervention during dialysis and determine its effects on dialysis adequacy in comparison to the traditional prescription of increased dialysis time. In particular, the study aims to explore the acute effects of exercise during dialysis on the removal of several established uremic toxins.

Interventions

OTHERExercise

Exercise During Dialysis Patients will be asked to carry out cycling exercise for 60 minutes during the third quarter of their routine haemodialysis session. Exercise can be carried out in ten minute bouts with several minutes rest between bouts.

OTHERExtra time

An extra 30 minutes will be added to the currently prescribed treatment time of each patient.

Sponsors

Betsi Cadwaladr University Health Board
CollaboratorOTHER_GOV
B.Braun Avitum AG
CollaboratorINDUSTRY
Bangor University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stage 5 Chronic Kidney Disease * Receiving maintenance haemodialysis for \> 3 months

Exclusion criteria

* Unable to give consent * Present with contraindications to take part in exercise * Haemoglobin \<11 g/dL * Access recirculation * Chronic persistent hypotension with pre dialysis systolic blood pressures \<100mgHg. * Episodic treatment induced hypotension with frequent drops in intradialytic systolic blood pressure \>30mmgHg * Unstable medical condition * Currently taking medication affecting urea or creatinine generation

Design outcomes

Primary

MeasureTime frameDescription
Urea clearanceOne dialysis sessionThe primary outcome is urea clearance which will be measured by continuously sampling waste dialysate from an entire dialysis session.

Secondary

MeasureTime frameDescription
Urea clearanceOne dialysis sessionUrea clearance which will be measured by continuously sampling UV absorbance of waste dialysate during an entire dialysis session.

Countries

United Kingdom

Contacts

Primary ContactJamie H Macdonald, PhD
j.h.macdonald@bangor.ac.uk0044 1248 383272

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026